SRS Capital Advisors »

Prime Medicine shares owned by SRS Capital Advisors

Quarter-by-quarter ownership of Prime Medicine (PRME) shares owned by SRS Capital Advisors from 13F filings

Historical chart of SRS Capital Advisors investment in Prime Medicine

Tip: Access up to 7 years of quarterly data

All positions including Prime Medicine held by SRS Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Prime Medicine by SRS Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $30k 5.4k 5.54
2024-09-30 $537 139 3.87
2024-06-30 $715 139 5.14

More positions owned by SRS Capital Advisors

Vanguard Index Fds Growth Etf (VOO)
Ishares Tr Ishs 1-5yr Invs (OEF)
First Tr Exchange-traded Wtr Etf (FDL)
American Centy Etf Tr Us Large Cap Vlu (KORP)
Dimensional Etf Trust Intl Core Equity (DFAI)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Schwab Strategic Tr Us Tips Etf (SCHB)
Microsoft Corporation (MSFT)
First Tr Exchng Traded Fd Vi Smith Opport Fxd (FIXD)
First Tr Exchange Traded Risng Divd Achiv (FXN)
NVIDIA Corporation (NVDA)
First Tr Exch Traded Fd Iii Pfd Secs Inc Etf (FPE)
Spdr S&p 500 Etf Tr Tr Unit
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)

View all positions for SRS Capital Advisors

Top funds holding Prime Medicine

Alphabet
T. Rowe Price Investment Management
BlackRock
ARK Investment Management
Vanguard Group
Farallon Capital Management
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Casdin Capital
Woodline Partners
RA Capital Management
FMR
D. E. Shaw & Co
MWG Management
Geode Capital Management

View all funds holding Prime Medicine